CSAM HEALTH GROUP NK 10
Omda AS provides software solutions for the healthcare and emergency response sector in Norway, Sweden, Denmark, Finland, and internationally. The company offers laboratory information management systems consisting of Omda ProSang, a blood, cell, and tissue management system; and medical medication solution comprising Omda Cytodose, an oncology medication management solution. It also provides con… Read more
Market Cap & Net Worth: CSAM HEALTH GROUP NK 10 (6Q1)
CSAM HEALTH GROUP NK 10 (F:6Q1) has a market capitalization of $75.36 Million (€73.42 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #24299 globally and #2655 in its home market, demonstrating a 7.19% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CSAM HEALTH GROUP NK 10's stock price €3.58 by its total outstanding shares 20507663 (20.51 Million).
CSAM HEALTH GROUP NK 10 Market Cap History: 2021 to 2026
CSAM HEALTH GROUP NK 10's market capitalization history from 2021 to 2026. Data shows change from $149.25 Million to $75.36 Million (-12.48% CAGR).
CSAM HEALTH GROUP NK 10 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CSAM HEALTH GROUP NK 10's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 6Q1 by Market Capitalization
Companies near CSAM HEALTH GROUP NK 10 in the global market cap rankings as of March 18, 2026.
Key companies related to CSAM HEALTH GROUP NK 10 by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #726 globally with a market cap of $27.95 Billion USD.
- BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ:BTSGU): Ranked #1050 globally with a market cap of $18.65 Billion USD.
- HealthEquity Inc (NASDAQ:HQY): Ranked #2289 globally with a market cap of $6.59 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2365 globally with a market cap of $6.28 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #726 | Veeva Systems Inc Class A | NYSE:VEEV | $27.95 Billion | $185.28 |
| #1050 | BrightSpring Health Services, Inc. Tangible Equity Unit | NASDAQ:BTSGU | $18.65 Billion | $131.16 |
| #2289 | HealthEquity Inc | NASDAQ:HQY | $6.59 Billion | $78.67 |
| #2365 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $6.28 Billion | $39.05 |
CSAM HEALTH GROUP NK 10 Historical Marketcap From 2021 to 2026
Between 2021 and today, CSAM HEALTH GROUP NK 10's market cap moved from $149.25 Million to $ 75.36 Million, with a yearly change of -12.48%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €75.36 Million | -15.57% |
| 2025 | €89.25 Million | +67.59% |
| 2024 | €53.26 Million | -9.68% |
| 2023 | €58.96 Million | -10.19% |
| 2022 | €65.65 Million | -56.01% |
| 2021 | €149.25 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of CSAM HEALTH GROUP NK 10 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $75.36 Million USD |
| MoneyControl | $75.36 Million USD |
| MarketWatch | $75.36 Million USD |
| marketcap.company | $75.36 Million USD |
| Reuters | $75.36 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.